Scherle, Peggy
Prelude Therapeutics,
United States
2024 Rank: 388507
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2077 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 388507 | 451347 |
| Total Cites | 684 | 697 |
| H-index | 14 | 14 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 10 | 10 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 99 | 100 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 589 | 599 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.16 |
| Self-Citation Percentage |
1.87%
|
|
Scherle, Peggy
Prelude Therapeutics,
United States
2023 Rank: 337969
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1754 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 337969 | 381058 |
| Total Cites | 768 | 783 |
| H-index | 14 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 10 | 10 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 119 | 119 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 657 | 669 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.17 |
| Self-Citation Percentage |
1.92%
|
|
Scherle, Peggy
Incyte Research Institute,
United States
2022 Rank: 187768
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 775 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 187768 | 221186 |
| Total Cites | 902 | 924 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 21 | 21 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 172 | 174 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 752 | 770 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.20 |
| Self-Citation Percentage |
2.38%
|
|
Scherle, Peggy
Prelude Therapeutics,
United States
2021 Rank: 231168
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 984 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 231168 | 271133 |
| Total Cites | 1281 | 1317 |
| H-index | 18 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 27 | 27 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 250 | 253 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1060 | 1085 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.21 |
| Self-Citation Percentage |
2.73%
|
|
Scherle, Peggy
Incyte Research Institute,
United States
2020 Rank: 214548
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 935 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 214548 | 252370 |
| Total Cites | 920 | 951 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 17 | 17 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 197 | 202 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 728 | 747 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
3.26%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.